Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vessela Kristensen

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|August 9, 2007
Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancerMontserrat Garcia-Closas, Vessela Kristensen, Anita Langerød, et al.
Oncoimmunology|November 1, 2018
Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumabShakila Jabeen, Manuela Zucknick, Marianne Nome, et al.
International Journal of Cancer|March 25, 2014
Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapyAnn Rita Halvorsen, Aslaug Helland, Thomas Fleischer, et al.
Oncoimmunology|February 5, 2019
Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristicsShakila Jabeen, Jaime A Espinoza, Lilly Anne Torland, et al.
International Journal of Cancer|June 4, 2020
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancerHedda von der Lippe Gythfeldt, Tonje Lien, Xavier Tekpli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor statusMontserrat Garcia-Closas, Melissa A Troester, Ying Qi, et al.
Molecular Oncology|January 7, 2014
The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumorsDavid A Quigley, Elisa Fiorito, Silje Nord, et al.
Future Oncology (London, England)|September 13, 2019
The NEOLETEXE trial: a neoadjuvant cross-over study exploring the lack of cross resistance between aromatase inhibitorsNazli Bahrami, Torill Sauer, Siri Engebretsen, et al.
BMC Cancer|November 20, 2014
Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control studyMari Tinholt, Marte Kathrine Viken, Anders Erik Dahm, et al.
Communications Biology|April 4, 2020
DNA copy number motifs are strong and independent predictors of survival in breast cancerArne V Pladsen, Gro Nilsen, Oscar M Rueda, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|August 9, 2007
Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancerMontserrat Garcia-Closas, Vessela Kristensen, Anita Langerød, et al.
Oncoimmunology|November 1, 2018
Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumabShakila Jabeen, Manuela Zucknick, Marianne Nome, et al.
International Journal of Cancer|March 25, 2014
Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapyAnn Rita Halvorsen, Aslaug Helland, Thomas Fleischer, et al.
Oncoimmunology|February 5, 2019
Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristicsShakila Jabeen, Jaime A Espinoza, Lilly Anne Torland, et al.
International Journal of Cancer|June 4, 2020
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancerHedda von der Lippe Gythfeldt, Tonje Lien, Xavier Tekpli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor statusMontserrat Garcia-Closas, Melissa A Troester, Ying Qi, et al.
Molecular Oncology|January 7, 2014
The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumorsDavid A Quigley, Elisa Fiorito, Silje Nord, et al.
Future Oncology (London, England)|September 13, 2019
The NEOLETEXE trial: a neoadjuvant cross-over study exploring the lack of cross resistance between aromatase inhibitorsNazli Bahrami, Torill Sauer, Siri Engebretsen, et al.
BMC Cancer|November 20, 2014
Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control studyMari Tinholt, Marte Kathrine Viken, Anders Erik Dahm, et al.
Communications Biology|April 4, 2020
DNA copy number motifs are strong and independent predictors of survival in breast cancerArne V Pladsen, Gro Nilsen, Oscar M Rueda, et al.
Pageof 10